Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Evonetix
Evonetix
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Evonetix delivers chip-synthesised DNA to the University of Cambridge
The DNA was delivered to Dr Jenny Molloy, Co-chair of the Engineering Biology Interdisciplinary Research Centre at the University of Cambridge
Evonetix attains DNA synthesis patent
The company’s approach to parallel DNA synthesis is underpinned by independent control of temperature at thousands of individual synthesis sites across the surface of a silicon chip
Ingredients
Evonetix achieves enzymatic DNA synthesis
Dr Raquel Sanches-Kuiper, VP of Technology at Evonetix, directed the research
Regulatory
Evonetix granted patent for DNA data storage tech
The company’s DNA-on-chip platform uses individually controlled ‘virtual wells’ to enable either de-novo DNA synthesis or immobilisation of pre-synthesised DNA for storage in-situ
Research & Development
Evonetix and Analog Devices collaborate on DNA synthesis platform
The two companies began working together in January 2019
Manufacturing
Synthetic biology company moves to Cambridge business park in the UK
UK-based gene synthesis specialist Evonetix is developing a desktop DNA synthesis platform based on a proprietary silicon chip
Manufacturing
Evonetix partner with LioniX to enable DNA synthesis at scale
Silicon processing techniques will be used to manufacture a silicon array using synergistic thermal control chemistry to deliver high-throughput assembly of high-fidelity gene-length DNA
Subscribe now